| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0008 |